Back in 2018 MJN was named the winning project in the health category of the first edition of the Fundación MAPFRE Awards for Social Innovation, boosted by IE. Since then, they have formed part of the Red Innova global community of social innovators, who have come through each edition of the awards.

Watching the Evolution of MJN

As the founder of Red Innova, I had the pleasure of getting to know the MJN team from day 1. In 2018 we did some design research about the people behind the projects of the awards, so that we could focus on the core activities that would be most impactful for them. Salva was generous enough to have a virtual coffee with me and explain more about MJN, its origins and its vision for the future. It seems like just yesterday that we had this first chat, but three years have already gone by and MJN has achieved so much. From technological advancements and certification successes, to the winning of countless awards and the launch of the product to the market, MJN has certainly been busy bringing impactful change to society.

One of the key activities we do in Red Innova is called “Monthly Milestones”.  In this activity, our members tell us about their achievements each month, which we then incorporate into a report that is shared with the closed community. The Monthly Milestones provides us with a great opportunity to celebrate the achievements of our members and share these updates with other entrepreneurs, mentors and experts in MAPFRE, Fundación MAPFRE and IE. As one of the earliest and most committed members of Red Innova, MJN has documented over 55 milestones with us, which is among the highest in the community.

In April 2021 we celebrated the Monthly Milestones Anniversary, in which we gathered all the milestones that MJN and other members had sent over the years, and turned them into personalised reports. Capturing the achievements of MJN in this way and creating a timeline of the major successes of the organisation really illustrates how much a bunch of  smart,dedicated people can achieve in just a few years. From Red Innova, it has been humbling to be able to accompany them in some way along their journey!

Community Spirit

Our community is designed to facilitate the scaling of social impact on two levels. Firstly, there’s the focus on projects and providing training through IE University, networking with other members and the networks of MAPFRE and IE, building collaborations and facilitating knowledge exchange. We also raise awareness of our members and their projects through activities like thought leadership. Over the years, MJN has contributed greatly to sharing their learnings with Red Innova and the wider society through writing articles about the SDGs, connecting with other members in our community events and sharing stories of their achievements, which in turn helps others learn.

This type of openness to sharing and collaboration is exactly what we need in order to scale social impact globally. Oftentimes startups may be apprehensive about sharing their news, stories or ideas with others, but if we have learned anything from the past 3 years of Red Innova and having members like MJN, it’s that we can go a lot further and change the world when we work together. Considering all of the progress the team has made in such a short amount of time, I personally can’t wait to see all of the great things that they will continue to achieve in the future!

About Red Innova

Red Innova is the global community of social innovators connected to the Fundación MAPFRE Awards for Social Innovation, boosted by IE. The community was established in 2018 and continues to scale. Each edition, we invite the semifinalist projects to be part of the exclusive community, which includes social entrepreneurs, directors from Fundación MAPFRE, MAPFRE and IE University, as well as our team of mentors, jury members and innovation experts. Our members come from all across the world, predominantly Latin America and Europe.

Author: Laura McDermott, Director of Red Innova
https://www.linkedin.com/in/lamcdermott/

Leave a Reply

Open chat
1
Contact with us now
Chat with Anna
¡Hola! 👋🏻
Soy Anna, ¿en qué puedo ayudarte?

The user who fills in the information requested in this form declares to be entitled to do so and is solely responsible for the accuracy and completeness of the data and information entered, expressly exonerating MJN NEUROSERVEIS of any liability that may arise for this entity on the occasion of the information provided through this form.

Yes, I accept

L’usuari que complimenta la informació requerida al present formulari declara estar legitimat per això i es fa responsable exclusiu de la veracitat i integritat de les dades i informació que introdueix, exonerant expressament a MJN NEUROSERVEIS de qualsevol responsabilitat que es pugi generar per aquesta entitat amb ocasió de la informació facilitat a través del present formulari.

Si, accepto

El usuario que cumplimenta la información requerida en el presente formulario declara estar legitimado para ello y se hace responsable exclusivo de la veracidad e integridad de los datos e información que introduce, exonerando expresamente a MJN NEUROSERVEIS de cualquier responsabilidad que pudiera generarse para esta entidad con ocasión de la información facilitada a través del presente formulario.

Sí, acepto

Save the date

The next Saturday 21st of November at 4 pm, you will be able to know first hand our product: mjn-SERAS.
mjn-SERAS is a healthcare product that sends a warning signal when the risk of epileptic seizures is high, to the affected person and their trusted contacts.

Sign up now!


    mjn-SERAS is a medical device with CE marking according to the European Directive 93/42/EEC and the Royal Decree RD. 1591/2009.
    Contraindications: Do not use the product if you suffer from an infection in the ear canal or if you suffer from a skin lesion in the vicinity of the product's area of influence.
    Considerations: This medical product works with an APP only on Android phones. The results tested are 96% sensitivity and 94% specificity.
    CPSP20103CAT.

    Save the date

    El próximo sábado 21 de noviembre a las 4 de la tarde, podrás conocer de primera mano nuestro producto: mjn-SERAS.
    mjn-SERAS es un producto sanitario que lanza una señal de aviso cuando el riesgo de crisis de epilepsia es elevado, a la persona afectada y a sus contactos de confianza.

    ¡Inscríbete!

      mjn-SERAS es un producto sanitario con marcado CE conforme a la Directiva Europea 93/42/EEC y el Real Decreto RD. 1591/2009.
      Contraindicaciones: No usar el producto en caso de padecer una infección en el canal auditivo o en caso de padecer una lesión cutánea en las proximidades del área de influencia del producto.
      Consideraciones: Este producto sanitario funciona con una APP solo en teléfonos Android. Los resultados testeados son 96% de sensibilidad y 94% de especificidad.
      CPSP20103CAT.